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Acute ischemic strokeAbstract The mean platelet volume (MPV) is a laboratory marker associated with platelet func-
tion and activity. Increased MPV in thromboembolic disease is reflected as an important risk factor.
The aim of this study was to compare the MPV and mean platelet volume/platelet count (MPV/PC)
ratio between ischemic cerebrovascular stroke and control subjects and furthermore, to find out
their diagnostic value in an acute setting to help risk stratification in patients with ischemic stroke.
Methods: The cross-sectional study was conducted in Kuwait city Medical Hospitals, the state of
Kuwait from April 2015 to October 2015. It comprised 50 consecutive patients with acute ischemic
stroke, and 20 healthy volunteers. Blood samples were taken to measure MPV and MPV/PC ratio.
The Severity of ischemic stroke was assessed by the Modified Rankin scale. Result: The ischemic
stroke patients had significantly higher MPV and MPV/PC ratio compared to the control group
(p= 0.001 and p= 0.017) respectively. The MPV value was higher and more significant
(p= 0.011) in patients group with high Rankin scale (P3) in comparison with those with lower
scores. Receiver operator characteristic analysis revealed that an MPV cutoff value of >8.1
femtoliters provided 68.0% sensitivity and 80.0% specificity. An MPV/PC cutoff value of
>0.031 fl104 lL1 showed 70% sensitivity and 75% specificity. The area under the ROC curve
for MPV and MPV/PC ratio was 0.789 and 0.701 respectively, which indicates the high
discriminative value of MPV and MPV/PC ratio for predicting severe ischemic stroke based on
Rankin score P3 from a mild stroke. Conclusion: MPV and MPV/PC ratio could be considered
meaningful laboratory markers for the risk of acute ischemic stroke.
 2016 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).






Age (years ±SD) 61.4 ± 13.5 y 53.6 ± 10.5 y 0.024
Sex: Male/female 27/23 8/12 0.290
PC, 104/lL 2.66 ± 82.96 2.66 ± 61.28 0.482
MPV, FL 8.99 ± 1.54 7.67 ± 0.89 0.001
MPV/PC ratio,
fl104 lL1
0.036 ± 0.010 0.030 ± 0.007 0.017
PC: platelet count; MPV: mean platelet volume.
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The mean platelet volume (MPV) is one of the most commonly
used laboratory markers related platelet functions.1,2 Because
of their greater content in granules, large platelets are more
reactive than ordinary size platelets,3,4 produce more pro-
thrombotic factors, and show greater aggregation to adenosine
diphosphate (ADP), collagen or adrenaline and secrete more
thromboxane A2 (TxA2).5,6. Increased platelet size has been
described in patients with vascular risk factors such as dia-
betes,7 Hypercholesterolemia,8 metabolic syndrome 9 and in
patients with renal artery stenosis.10 Higher mean platelet vol-
ume (MPV) values have been established in patients with
stroke6,11 and acute myocardial infarction12,13 than in control
subjects. Furthermore, MPV has been shown to be predictive
of stroke, in patients with previous cerebrovascular events,
even 3.9 years before the original event.14 Additionally, a high
ratio of MPV to platelet count (MPV/P) is considered a risk
factor for various diseases and is associated with myocardial
infarction, anemia, and hepatocellular carcinoma.15,16 The
connections between MPV with cerebrovascular accidents
and their prognosis have already been questioned. Particular
studies detected an increased MPV in different subtypes of
brain stroke, both in the acute phase and long after disease.17
Also, stroke patients with high mortality have been found to
have a low platelet count.11 These results lead to the hypothesis
that the increase of MPV might have a critical role in the
genesis or deterioration of brain stroke.
However, until now no studies have sufficiently assessed the
role of MPV and MPV/PC ratio during acute ischemic events.
The aim of this study was to compare the MPV and MPV/PC
ratio between ischemic cerebrovascular stroke and control sub-
jects and also to find out their diagnostic value in an acute set-
ting to help risk stratification in patients with ischemic stroke.
2. Methods
2.1. Patients
The cross-sectional study conducted in the emergency depart-
ment of Kuwait city Medical Hospitals in the state of Kuwait
from April 2015 to October 2015 and comprised 50 patients
with first acute ischemic stroke. The control group consisted
of 20 age and sex matched healthy volunteers with no clinical
evidence of any active vascular disease, previous cerebrovascu-
lar disease, malignancy or infarction and not taking medica-
tions known to affect platelet function. All data were
collected, including demographics, medical history, especially
previous history of ischemic heart disease or cerebrovascular
accidents, biochemical parameters, medications, echocardio-
graphic data, and neuroimaging studies. Exclusion criteria
are for patients who had peripheral vascular disease, prior
stroke, acute infection, positive C-reactive protein or inflamma-
tory conditions, pregnancy, acute myocardial infarction, malig-
nancies, cranial traumas, intracranial hemorrhage, hematomas,
or with transient symptoms of cerebrovascular diseases. The
diagnosis of ischemic stroke was made clinically with the evi-
dence of acute infarction confirmed by brain CT orMRI within
the first 24 h of presentation to the emergency department.
Severity of ischemic stroke was judged by Modified Rankin
scale that scores in patients on a scale of 0–6, with 0 beingasymptomatic and 6 being dead. Scores of 0–2 are considered
‘‘good” stroke consequences; in that these patients are able to
lead fairly independent lives and are able to return to work in
almost all cases. Scores of 3 or greater indicate that the patient
will need considerable help with their daily activities.
2.2. Platelet measurements
Blood samples were drawn from a forearm vein, collected into
tubes containing ethylenediaminetetraacetic acid (EDTA) and
stored at room temperature until measurement, which was per-
formed in all cases within 2 h after venipuncture. Platelet mea-
surements were analyzed by flow cytometry in automated
hematology analysis system (CELL-DYN Sapphire) that pro-
vided platelet count and MPV (in FL).
2.3. Statistical analysis
Statistical analysis was performed using SPSS 16.0 and
Medcalc statistical software. Results were expressed as mean
and Standard deviation. The comparison of groups with the
different Rankin score, and also a comparison of the MPV
and MPV/PC ratio among ischemic stroke patients and the
control were done as follows: normally distributed continuous
variables compared with 2-independent samples t-test, Mann
Whitney test was used for non-normally distributed continu-
ous variables and chi-Square test was used to compare qualita-
tive data. Statistical significance was made at p < 0.05. There
were no data about exact cutoff values for MPV or MPV/PC
ratio in ischemic cerebrovascular diseases. Therefore, Receiver
Operating Characteristic (ROC) curve analysis was done for
the determination of sensitivity and specificity of the cutoff
values of all patients. The area under the Receiver Operating
Characteristic (ROC) curve was used to estimate the perfor-
mance of MPV and MPV/pc ratio for discriminating severe
ischemic stroke from a mild event.
3. Results
Our study selected 50 patients presented with cerebrovascular
stroke besides 20 control subjects. Demographic characteristics
and baseline factors of participants are shown in Table 1.
The group of stroke patients composed of 23 females and 27
males, while the healthy controls comprised 12 females and 8
males (p > 0.05). The mean ages of the stroke patients were
61.4 ± 13.5 y and of the controls 53.6 ± 10.5 y (p= 0.024).
A statistically significant difference (p= 0.001) was
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Figure 1 Specificity and sensitivity of mean platelet volume in
















Mean platelet volume and volume/platelet count ratio as a tool 69(8.99 ± 1.54 FL) and the MPV values of the control group
(7.67 ± 0.89 FL). Also, there was a significant difference
(p= 0.017) between MPV/PC ratio between stroke patients
and control. Among 50 stroke patients16 were categorized as a
poor stroke outcome (Rankin scores P3) and others had the
lowest score. There was no significant difference according to
age, gender distribution and MPV/PC ratio (p > 0.05). But,
those with higher Rankin scale had a significantly more occur-
rence of previous ischemic heart disease (p< 0.001). In terms
of MPV levels and platelet count, there was a significant differ-
ence in comparison between groups with Rankin scoreP3 and
those with lower scores (p = 0.011 and p= 0.022) respectively
(Table 2). For all patients ROC curve analysis, the area under
the curve for MPV was 0.789 (95% confidence interval [CI],
0.675–0.877) (p< 0.0001) indicating the high discriminative
value of MPV for predicting severe ischemic stroke based on
Rankin score P3 from a mild stroke event. When MPV level
was taken as>8.1 femtoliter, a sensitivity of 68.0% and a speci-
ficity of 80.0% were found (Fig. 1). In concern of MPV/PC
ratio, the area under the curve was 0.701 (95% confidence inter-
val [CI], 0.579 to 0.804) (p < 0.0025).WhenMPV/PC ratio level
was taken as >0.031 fl104 lL1, a sensitivity of 70.0% and a
specificity of 75.0% were found (Fig. 2).
4. Discussion
MPV has been identified to be of clinical importance in throm-
boembolic diseases. Increment in the mean platelet volume
(MPV) level has been observed in patients with stroke18 and
acute myocardial infarction13 than in control subjects. In our
study, we found that MPV andMPV/PC ratio was significantly
higher in patients presenting with cerebrovascular stroke com-
pared to a control group. Similarly, O’Malley et al.5 found
greater MPV values in patients with acute ischemic stroke than
in controls. Conversely, Cho et al. did not find any significant
difference between patients and controls in relation toMPV val-
ues,19 but most of the studies proved that MPV levels were
higher in stroke patients.20,21 The current study evaluated the
role of MPV for expecting severe and extensive acute ischemic
brain stroke from its mild status, and it showed that measuring
MPV within the first 24 h of brain stroke occurrence was
strongly associated with the severity of disease, and could effec-
tively distinguish a severe condition from a milder degree of theTable 2 Baseline characteristics and clinical data according to
the severity of CVA.





Age (years ±SD) 59.8 ± 13.3 64.8 ± 13.9 0.228
Sex
Male 17(50)% 10(62.5%) 0.407
Female 17(50)% 6(37.5%)
History of IHD, n
(%)
3(8.8%) 4(25%) <0.001
PC, 104/lL 2.55 ± 81.71 2.91 ± 82.84 0.022
MPV, FL 8.62 ± 1.39 9.78 ± 1.57 0.011
MPV/PC ratio, FL
104 lL1
.036 ± .010 .036 ± .011 0.984
CVA: cerebrovascular accident; IHD: ischemic heart disease; PC:
platelet count; MPV: mean platelet volume.
Figure 2 Specificity and sensitivity of mean platelet volume in
predicting ischemic stroke severity. Area under the curve: 0.701,
standard error: 0.0664.disorder. Also, we revealed that MPV increases early in the
strokes characterized by more neurological impairment in com-
parison with those with less compromised categories according
to modified Rankin score. This may indicate more release of
reactive platelets in the circulation in reaction to mediators
coming from the peripheral ischemic sites. Actually, the fact
that MPV may be raised before the acute event has clearly been
demonstrated by the PROGRESS study14 which stated an 11%
rise of the relative risk of stroke for every femtoliter of MPV
increment in 3134 individuals with prior cerebrovascular dis-
ease, prospectively followed for a median period of 3.9 years.
Thus, subjects with large platelets have an increased risk of
ischemic stroke. Butterworth et al.6 reported that there was a
lower platelet count in the stroke group, whereas some studies
showed that patients with acute ischemic stroke had higher
70 A.M. Elsayed, G.A. Mohamedplatelet counts than the control groups which came in compat-
ible with our result.11,22 Cho et al.19 showed that MPV levels
were higher in female patients than in male. In contrast, We
did not find significant difference in MPV or MPV/PC ratio
according to gender. Hypertension, DM, coronary heart dis-
ease, smoking and hyperlipidemia have an impact on MPV.13
But in some studies, no influence of vascular risk factors on
MPV was found.23,24 In our study, there was no clear associa-
tion of MPV with IHD; this came in accordance with study
done by Fu¨ sun et al.17 who did not report an association of
MPV with coronary events. Our ROC analysis verified that
MPV (cutoff value of >8.1 FL) and MPV/PC ratio (cutoff
value of>0.031 FL 104 lL1)) could be used as surrogate lab-
oratory markers for detecting cerebrovascular stroke with 68%
and 70% sensitivity and 80% and 75% specificity, respectively.
In comparison Nurettin et al.25 reported that an MPV cutoff
value of 9.95 femtoliter had 46.2% sensitivity and 80.0%
specificity.
5. Conclusion
Increased MPV and MPV/PC ratio is related to cerebrovascu-
lar stroke. Also the MPV and MPV/PC ratio tests considered a
simple, cost-effective and meaningful laboratory markers test
for early detection and risk stratification of cerebrovascular
stroke.
6. Recommendation
According to our results, we recommended further studies to
investigate the role of MPV and MPV/PC ratio as a prognostic
factor in the severity of ischemic stroke and its outcome.
7. Limitation of the study
Our study had some limitations: We measured MPV only in
the Emergency Department (ED) and did not perform further
serial measurements during the following days. Serial measure-
ments might be useful in studying the prognosis of the patients.
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